CBP issued the following releases on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters:
International Trade Today is providing readers with some of the top stories for Dec. 30 - Jan. 3 in case they were missed.
CBP issued the following releases on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters:
The Food and Drug Administration seeks comments on its data requirements for imports and electronic entries as it submits them to the Office of Management and Budget for reapproval, FDA said in a notice. The agency seeks comments on the necessity of its ACE filing requirements, their burden on importers and exporters, and ways to improve the information collection. FDA is revising its OMB approval request to add information collected via its weekly entry filing program for foreign-trade zones, as well as information collected by way of the agency's Import Trade Auxiliary Communication System. Comments are due March 3.
CBP issued the following releases on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters:
CBP has not updated ACE yet with the extensions granted to six Section 301 exclusions that were set to expire on Dec. 28, the agency said in a CSMS message. “CBP expects the update to be soon after 1/2/2020 and will provide an update when programming is complete and ready to accept transmission of HTS 9903.88.05 on entries with entry dates beyond 12/28/2019,” CBP said. Twenty-five of the original set of Section 301 exclusions expired on Dec. 28 (see 1912190060).